HomeCommentary

Commentary

Will Drug Makers Move to Pull Plug on Off-Patent Brands under “G1” Scheme?
(Mar.12.2018)

By Takashi Ebisawa

With Japan to significantly shave the NHI prices of off-patent brand-name medicines in its drug price revision next month, all eyes are now on whether pharma companies will move to pull their products off the market under a new scheme that allows such withdrawal under certain conditions ...

(LOG IN FOR FULL STORY)

News Calendar